Regulatory Policy - The Hong Kong Insurance Authority initiated a public consultation on the risk-based capital regime on February 11, 2026, proposing preferential capital treatment for eligible infrastructure investments and revising capital requirements for general business, with the consultation period ending on March 10, 2026. This policy may impact the capital allocation strategies of insurance institutions operating in Hong Kong [2]. Company Status - Changsheng Life Insurance disclosed its solvency report for Q4 2025 on February 2026, showing a comprehensive solvency ratio of 79.7% and a core solvency ratio of 64.8%, both below regulatory minimums (100% and 50% respectively). The company reported a net asset of -226 million yuan, indicating insolvency. It forecasts a further decline in solvency indicators for Q1 2026 (comprehensive ratio of 50.3% and core ratio of 32.3%), facing risks of regulatory discussions and dividend restrictions [3]. Industry Policy and Environment - The insurance sector performed strongly in 2025, with the insurance index rising by 31.31% for the year, although disparities increased. Leading insurers like China Ping An saw a 46.2% year-on-year growth in new business value for the first three quarters of 2025, while some non-listed insurers, such as Changsheng Life, experienced a 32.39% decline in insurance revenue and a net loss of 512 million yuan. Ongoing policy optimizations, such as the Financial Regulatory Bureau's reduction of investment risk factors in December 2025, may provide long-term benefits to the industry's asset side [4].